☆ 4.8 Article

Combined analysis of bulk and single-cell RNA sequencing reveals novel natural killer cell-related prognostic biomarkers for predicting immunotherapeutic response in hepatocellular carcinoma

FRONTIERS IN IMMUNOLOGY (2023)

Related references

Note: Only part of the references are listed.

Review Immunology

Understanding the squamous cell carcinoma immune microenvironment

Vahide Saeidi et al.

Summary: Primary cutaneous squamous cell carcinoma (cSCC) is the second most common human cancer with a rising incidence of about 1.8 million in the United States annually. Surgery is usually curative, but in some cases, cSCC can metastasize and result in death. The introduction of checkpoint inhibitor immunotherapy has significantly improved treatment outcomes for advanced or metastatic cSCC.

FRONTIERS IN IMMUNOLOGY (2023)

Add to Collection

Review Gastroenterology & Hepatology

The liver cancer immune microenvironment: Therapeutic implications for hepatocellular carcinoma

Romain Donne et al.

Summary: The liver is a common site for primary cancer and a major cause of cancer death. Hepatocellular carcinoma (HCC) accounts for the majority of liver cancers. Immune-checkpoint inhibitors have shown promise in the treatment of HCC, but further understanding of the tumor microenvironment and the development of additional biomarkers are needed. Other immune-targeting strategies are also being developed. This review provides an overview of the HCC immune microenvironment and current immunotherapies.

HEPATOLOGY (2023)

Add to Collection

Article Hematology

Association between the choice of the conditioning regimen and outcomes of allogeneic hematopoietic cell transplantation for myelofibrosis

Guru Subramanian Guru Murthy et al.

Summary: Allogeneic hematopoietic cell transplantation (allo-HCT) is the only curative treatment for myelofibrosis. However, the optimal conditioning regimen for this procedure is still unknown.

HAEMATOLOGICA (2023)

Add to Collection

Review Clinical Neurology

Disease-modifying therapies for relapsing/active secondary progressive multiple sclerosis - a review of population-specific evidence from randomized clinical trials

Antonios Bayas et al.

Summary: Although the understanding of SPMS is evolving, early detection of relapse-independent progression remains difficult. The term RMS includes RRMS and SPMS with relapses, and disease-modifying therapies approved for RMS or active SPMS are used. However, there are differences in efficacy and safety evidence between drugs approved for RMS and SPMS. Clinical trials have shown that siponimod and interferon-beta 1b s.c. have significant reductions in disability progression in SPMS populations, but data on other drugs approved for RMS are limited to small subgroups and the potential to reduce relapse-independent progression is unclear.

THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS (2023)

Add to Collection

Article Cell Biology

Defined tumor antigen-specific T cells potentiate personalized TCR-T cell therapy and prediction of immunotherapy response

Jingjing He et al.

Summary: Personalized immunotherapy targeting tumor-specific antigens (TSAs) can be achieved by activating T cells specific for these antigens, but precise prediction of neoantigens from tumor mutations is challenging. This study identified a specific type of T cells (Tas cells) in tumors that can be targeted for personalized immunotherapy. The level of Tas cells in tumors can accurately predict the response to immunotherapy.

CELL RESEARCH (2022)

Add to Collection

Review Biochemistry & Molecular Biology

Expanding uncapped translation and emerging function of circular RNA in carcinomas and noncarcinomas

Yan Wang et al.

Summary: This article discusses the translation mechanisms of circular RNAs and their role in regulating human diseases. It has been discovered that circular RNAs can be translated into proteins through various mechanisms, providing new insights into the understanding of noncanonical circular RNA translation and proteomics.

MOLECULAR CANCER (2022)

Add to Collection

Article Oncology

A novel strategy for combination of clofarabine and pictilisib is synergistic in gastric cancer

Shayan Khalafi et al.

Summary: The combination therapy of clofarabine and pictilisib in gastric cancer promotes DNA damage and inhibits key cell survival pathways to induce cell death more effectively than single-agent treatment.

TRANSLATIONAL ONCOLOGY (2022)

Add to Collection

Article Medicine, Research & Experimental

Single-cell RNA sequencing reveals a pro-invasive cancer-associated fibroblast subgroup associated with poor clinical outcomes in patients with gastric cancer

Xuechun Li et al.

Summary: This study reveals the characteristics of different CAF subsets in gastric cancer (GC) and their interactions with the tumor microenvironment (TME) using single-cell RNA sequencing and multistaining registration techniques. The results demonstrate that iCAFs and eCAFs not only exhibit enhanced protumor activities, but also mobilize surrounding immune cells to construct a tumor-favorable microenvironment.

THERANOSTICS (2022)

Add to Collection

Article Oncology

Spatial Organization and Prognostic Significance of NK and NKT-like Cells via Multimarker Analysis of the Colorectal Cancer Microenvironment

Juha P. Vayrynen et al.

Summary: This study developed a multiplexed immunofluorescence assay coupled with digital image analysis and machine learning to identify different lymphocytic populations in colorectal cancer. The study found that T cells were more abundant than NK and NKT-like cells in colorectal cancer. NK cells expressed high levels of a cytotoxic marker and were located closer to tumor cells, while T and NKT-like cells expressing the marker were enriched in cells closer to tumor cells. Higher densities of T and NKT-like cells were associated with longer cancer-specific survival, as well as higher densities of GZMB(+) and FCGR3A(+) NK cells and closer proximity of T and NKT-like cells to tumor cells.

CANCER IMMUNOLOGY RESEARCH (2022)

Add to Collection

Article Oncology

Immune phenotypic linkage between colorectal cancer and liver metastasis

Yedan Liu et al.

Summary: The tumor microenvironment (TME) is influenced by cancer cells and host tissues, which play a role in shaping the immune composition within TME. This study identified different immune cell types associated with malignancy and niche, and also identified potential pro-metastasis factors.

CANCER CELL (2022)

Add to Collection

Article Gastroenterology & Hepatology

Topological analysis of hepatocellular carcinoma tumour microenvironment based on imaging mass cytometry reveals cellular neighbourhood regulated reversely by macrophages with different ontogeny

Jianpeng Sheng et al.

Summary: This study identified different functional units of HCC TME using imaging mass cytometry, with a focus on the importance of Kupffer cells in immunotherapy for HCC.

GUT (2022)

Add to Collection

Article Urology & Nephrology

Molecular and Pharmacological Bladder Cancer Therapy Screening: Discovery of Clofarabine as a Highly Active Compound

Iris E. Ertl et al.

Summary: The study aimed to establish a model system for drug identification and repurposing to identify novel therapies for the treatment of bladder cancer. The results showed that clofarabine exhibited inhibitory effects on bladder cancer cells, suggesting potential clinical relevance.

EUROPEAN UROLOGY (2022)

Add to Collection

Article Genetics & Heredity

Integrated analysis of single-cell and bulk RNA sequencing data reveals a pan-cancer stemness signature predicting immunotherapy response

Zhen Zhang et al.

Summary: By analyzing single-cell RNA sequencing data from ICI-treated patients, it was found that cancer stemness may be associated with resistance to ICI treatment. The developed novel stemness signature (Stem.Sig) showed improved predictive performance for ICI response across multiple cancers, potentially serving as a competitive tool for patient selection in immunotherapy.

GENOME MEDICINE (2022)

Add to Collection

Article Biochemical Research Methods

Immune infiltration and clinical significance analyses of the coagulation-related genes in hepatocellular carcinoma

Qifan He et al.

Summary: In this study, the correlation between coagulation and hepatocellular carcinoma (HCC) was investigated. It was found that coagulation is related to the tumor immune microenvironment (TME) of HCC. A coagulation-related risk score prognostic model was developed to predict the risk and prognosis of HCC patients. This model may have therapeutic benefits for chemotherapy and immunotherapy and can aid in clinical decision making.

BRIEFINGS IN BIOINFORMATICS (2022)

Add to Collection

Review Cell Biology

Aptamer nucleotide analog drug conjugates in the targeting therapy of cancers

Yongshu Li et al.

Summary: Aptamers are short single-strand oligonucleotides that can target specific biomarkers with high affinity and specificity. They have shown potential in cancer-targeting therapies, especially when conjugated with nucleotide analog drugs.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2022)

Add to Collection

Article Multidisciplinary Sciences

A single-cell atlas of the multicellular ecosystem of primary and metastatic hepatocellular carcinoma

Yiming Lu et al.

Summary: The authors use single cell RNA sequencing to study the immune cell constituents and localization within human hepatocellular carcinoma, providing insights into the microenvironment of the cancer.

NATURE COMMUNICATIONS (2022)

Add to Collection

Review Immunology

The Dynamic Role of NK Cells in Liver Cancers: Role in HCC and HBV Associated HCC and Its Therapeutic Implications

Muhammad Sajid et al.

Summary: Hepatocellular carcinoma (HCC) is a significant complication of chronic liver disease with various treatment strategies including surgery, loco-regional techniques, and chemotherapy. Natural killer (NK) cells play a vital role in fighting tumors and infections, but deviations in their function have been observed in HCC patients. The rate of recurrence of tumor-infiltrating and circulating NK cells is associated with improved survival in HCC, indicating the importance of NK cell dysfunction in HCC progression.

FRONTIERS IN IMMUNOLOGY (2022)

Add to Collection

Article Immunology

Identification and Validation of a Novel Signature Based on NK Cell Marker Genes to Predict Prognosis and Immunotherapy Response in Lung Adenocarcinoma by Integrated Analysis of Single-Cell and Bulk RNA-Sequencing

Peng Song et al.

Summary: This study identified 189 NK cell marker genes and developed a seven-gene prognostic signature based on these genes to predict the prognosis and immunotherapy response of lung adenocarcinoma patients. The signature was found to be an independent prognostic factor and low-risk patients had better immune cell infiltration and immunotherapy responses.

FRONTIERS IN IMMUNOLOGY (2022)

Add to Collection

Review Clinical Neurology

Acute idiosyncratic liver injury after Cladribine treatment for multiple sclerosis: first case report and review on associated hepatic disorders

Lorenzo Saraceno et al.

Summary: In recent years, several disease-modifying therapies have been developed for the treatment of multiple sclerosis (MS), including Cladribine. However, we describe a case of acute liver injury following treatment with Cladribine. Post-marketing adverse event reporting is crucial for early recognition and treatment, and understanding the physiopathological mechanism underlying drug-induced hepatic toxicity can provide valuable tools for clinicians in prevention and treatment.

MULTIPLE SCLEROSIS JOURNAL (2022)

Add to Collection

Article Immunology

Regulatory T-cells-related signature for identifying a prognostic subtype of hepatocellular carcinoma with an exhausted tumor microenvironment

Genhao Zhang

Summary: This study established a Tregs-related prognostic model that accurately predicts the prognosis of hepatocellular cancer patients. The study also identified TME-exhausted subpopulations and revealed the impact of PD1/PD-L1 inhibitors on the expression levels of HMOX1, MMP9, and TNFRSF11B in Hep3B and Huh7 cells.

FRONTIERS IN IMMUNOLOGY (2022)

Add to Collection

Review Immunology

Natural killer cells in antiviral immunity

Niklas K. Bjorkstrom et al.

Summary: This review explores the role of natural killer cells in acute and chronic viral infections, particularly focusing on insights from patients with primary immunodeficiencies. It also discusses the involvement of natural killer cells in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. The review highlights the importance of NK cells in innate immune responses to viral infections and provides recent insights into their role in human studies.

NATURE REVIEWS IMMUNOLOGY (2022)

Add to Collection

Review Oncology

NK cell-based cancer immunotherapy: from basic biology to clinical development

Sizhe Liu et al.

Summary: NK cells, as a specialized immune effector cell type, play a critical role in immune activation against abnormal cells. Unlike T cell activation, NK cell activation is governed by interactions between NK receptors and target cells, leading to significant attention in cancer immunotherapy. Many efforts are focused on developing and engineering NK cell-based cancer immunotherapy.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2021)

Add to Collection

Article Cell Biology

High expression of vinculin predicts poor prognosis and distant metastasis and associates with influencing tumor-associated nk cell infiltration and epithelial-mesenchymal transition in gastric cancer

Huafu Li et al.

Aging-US (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Development and validation of a novel lipid metabolism-related gene prognostic signature and candidate drugs for patients with bladder cancer

Ke Zhu et al.

Summary: This study successfully constructed an 11-LRG signature to predict the prognosis of BLCA patients, identified it as an independent hazardous factor, and found its close relationship with immune cell infiltration. Five small molecule drugs were identified as candidate treatments for BLCA patients based on the CMAP dataset.

LIPIDS IN HEALTH AND DISEASE (2021)

Add to Collection

Article Medicine, Research & Experimental

Percentage of Natural Killer (NK) Cells in Peripheral Blood Is Associated with Prognosis in Patients with Gastric Cancer: A Retrospective Study from a Single Center

Ming-zhi Xie et al.

Summary: In this study involving 180 gastric cancer patients, it was found that patients with a higher percentage of NK cells had longer survival times and could serve as an independent prognostic indicator for gastric cancer. NK cell percentage was positively correlated with lymphocyte count and albumin, while negatively correlated with CA125 and neutrophil-lymphocyte ratio. NK cells showed predictive value for the 5-year survival rate of gastric cancer, especially when combined with neutrophil-lymphocyte ratio. Patients at early T, N, and clinical stages tended to have a higher percentage of NK cells compared to those at advanced stages.

MEDICAL SCIENCE MONITOR (2021)

Add to Collection

Article Oncology

Memory-like Differentiation Enhances NK Cell Responses to Melanoma

Nancy D. Marin et al.

Summary: The treatment of advanced melanoma is a clinical challenge, and natural killer (NK) cells show promise as a cellular therapy. Cytokine-induced memory-like (ML) differentiation enhances NK-cell responses against blood cancer targets, but its activity against solid tumors like melanoma needs further research. In preclinical studies, ML NK cells from healthy donors and melanoma patients exhibited increased IFN gamma production and cytotoxicity against melanoma targets, with a response partially dependent on activating receptors NKG2D and NKp46. Furthermore, in mouse models, ML NK cells showed better control of melanoma compared to conventional NK cells.

CLINICAL CANCER RESEARCH (2021)

Add to Collection

Review Pharmacology & Pharmacy

Review of Transporter Substrate, Inhibitor, and Inducer Characteristics of Cladribine

Robert Hermann et al.

Summary: Cladribine is a drug used to treat patients with relapsing multiple sclerosis, which is phosphorylated in target cells to its active adenosine triphosphate form. The distribution of cladribine across biological membranes is facilitated by several uptake and efflux transporters, and it plays a role in intestinal absorption, distribution throughout the body, and intracellular uptake.

CLINICAL PHARMACOKINETICS (2021)

Add to Collection

Review Gastroenterology & Hepatology

Hepatocellular carcinoma in viral and autoimmune liver diseases: Role of CD4+CD25+Foxp3+regulatory T cells in the immune microenvironment

Alessandro Granito et al.

Summary: Over 90% of hepatocellular carcinoma cases occur in patients with cirrhosis, with hepatitis B virus and hepatitis C virus as leading causes. Immunotherapy has revolutionized HCC treatment by targeting immune cells rather than cancer cells, particularly focusing on regulatory T cells for their role in tumor progression and response to immune checkpoint inhibitors.

WORLD JOURNAL OF GASTROENTEROLOGY (2021)

Add to Collection

Article Oncology

Recombinant adenovirus expressing the fusion protein PD1PVR improves CD8+ T cell-mediated antitumor efficacy with long-term tumor-specific immune surveillance in hepatocellular carcinoma

Hailin Zhang et al.

Summary: The newly designed recombinant Ad5sPD1PVR virus significantly enhances CD8(+) T cell-mediated antitumor efficacy with long-term tumor-specific immune surveillance in hepatocellular carcinoma, and fludarabine is a promising therapeutic partner for Ad5sPD1PVR.

CELLULAR ONCOLOGY (2021)

Add to Collection

Article Gastroenterology & Hepatology

A new high-content screening assay of the entire hepatitis B virus life cycle identifies novel antivirals

Jaewon Yang et al.

Summary: This study developed a platform to investigate the entire HBV life cycle, screened and identified novel HBV inhibitors, and demonstrated the effectiveness of different drugs in inhibiting various stages of the viral life cycle. The high-content assay provides a valuable tool for studying HBV and developing new therapeutic strategies.

JHEP REPORTS (2021)

Add to Collection

Article Medicine, Research & Experimental

Comprehensive characterization of tumor infiltrating natural killer cells and clinical significance in hepatocellular carcinoma based on gene expression profiles

Mei Wu et al.

BIOMEDICINE & PHARMACOTHERAPY (2020)

Add to Collection

Article Oncology

Randomized Phase II Study of First-Line Cladribine With Concurrent or Delayed Rituximab in Patients With Hairy Cell Leukemia

Dai Chihara et al.

JOURNAL OF CLINICAL ONCOLOGY (2020)

Add to Collection

Review Biotechnology & Applied Microbiology

NK cells for cancer immunotherapy

Noriko Shimasaki et al.

NATURE REVIEWS DRUG DISCOVERY (2020)

Add to Collection

Meeting Abstract Oncology

Targeting autopalmitoylation of TEAD transcription factors

Xu Wu

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2020)

Add to Collection

Review Immunology

NK Cell Metabolism and Tumor Microenvironment

Inigo Terren et al.

FRONTIERS IN IMMUNOLOGY (2019)

Add to Collection

Article Biotechnology & Applied Microbiology

Integrating single-cell transcriptomic data across different conditions, technologies, and species

Andrew Butler et al.

NATURE BIOTECHNOLOGY (2018)

Add to Collection

Article Biochemistry & Molecular Biology

Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response

Peng Jiang et al.

NATURE MEDICINE (2018)

Add to Collection

Article Biochemistry & Molecular Biology

Novel Clofarabine-Based Combinations with Polyphenols Epigenetically Reactivate Retinoic Acid Receptor Beta, Inhibit Cell Growth, and Induce Apoptosis of Breast Cancer Cells

Katarzyna Lubecka et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)

Add to Collection

Article Oncology

High NKG2A expression contributes to NK cell exhaustion and predicts a poor prognosis of patients with liver cancer

Cheng Sun et al.

ONCOIMMUNOLOGY (2017)

Add to Collection

Article Biochemistry & Molecular Biology

GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses

Zefang Tang et al.

NUCLEIC ACIDS RESEARCH (2017)

Add to Collection

Meeting Abstract Oncology

In vitro and in vivo characterization of novel scorpion venom-based peptides for the treatment of colon cancer

Bin Li et al.

CANCER RESEARCH (2017)

Add to Collection

Article Oncology

Natural killer cells phenotypic characterization as an outcome predictor of HCV-linked HCC after curative treatments

Elisabetta Cariani et al.

ONCOIMMUNOLOGY (2016)

Add to Collection

Article Biochemistry & Molecular Biology

The prognostic landscape of genes and infiltrating immune cells across human cancers

Andrew J. Gentles et al.

NATURE MEDICINE (2015)

Add to Collection

Article Multidisciplinary Sciences

Inferring tumour purity and stromal and immune cell admixture from expression data

Kosuke Yoshihara et al.

NATURE COMMUNICATIONS (2013)

Add to Collection

Article Oncology

CellMiner: A Web-Based Suite of Genomic and Pharmacologic Tools to Explore Transcript and Drug Patterns in the NCI-60 Cell Line Set

William C. Reinhold et al.

CANCER RESEARCH (2012)

Add to Collection

Article Biochemical Research Methods

A roadmap to generate renewable protein binders to the human proteome

Karen Colwill et al.

NATURE METHODS (2011)

Add to Collection

Review Biotechnology & Applied Microbiology

Discovery and development of clofarabine: a nucleoside analogue for treating cancer

Peter L. Bonate et al.

NATURE REVIEWS DRUG DISCOVERY (2006)

Add to Collection

© Peeref 2019-2024. All rights reserved.